These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole. Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174 [TBL] [Abstract][Full Text] [Related]
45. 4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection. Calvet CM; Choi JY; Thomas D; Suzuki B; Hirata K; Lostracco-Johnson S; de Mesquita LB; Nogueira A; Meuser-Batista M; Silva TA; Siqueira-Neto JL; Roush WR; de Souza Pereira MC; McKerrow JH; Podust LM PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006132. PubMed ID: 29281643 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV. Zanusso Junior G; Massago M; Kian D; Toledo MJO Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891 [TBL] [Abstract][Full Text] [Related]
47. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034 [TBL] [Abstract][Full Text] [Related]
48. Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study. Colantonio LD; Prado N; Segura EL; Sosa-Estani S PLoS Negl Trop Dis; 2016 May; 10(5):e0004651. PubMed ID: 27158908 [TBL] [Abstract][Full Text] [Related]
49. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi. Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275 [TBL] [Abstract][Full Text] [Related]
50. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target. Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250 [TBL] [Abstract][Full Text] [Related]
51. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up. Álvarez MG; Ramírez JC; Bertocchi G; Fernández M; Hernández Y; Lococo B; Lopez-Albizu C; Schijman A; Cura C; Abril M; Laucella S; Tarleton RL; Natale MA; Castro Eiro M; Sosa-Estani S; Viotti R Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571827 [TBL] [Abstract][Full Text] [Related]
52. Systematic Review and Meta-analysis of the Pharmacokinetics of Benznidazole in the Treatment of Chagas Disease. Wiens MO; Kanters S; Mills E; Peregrina Lucano AA; Gold S; Ayers D; Ferrero L; Krolewiecki A Antimicrob Agents Chemother; 2016 Dec; 60(12):7035-7042. PubMed ID: 27550362 [TBL] [Abstract][Full Text] [Related]